Castle Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CSTL for the last quarter is 66.12 M USD, and it's 7.52% higher compared to the previous quarter. The net income of Q4 23 is -2.58 M USD.